Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin.

A hit optimization procedure based on isosteric and bioisosteric replacement of decorating groups at both the N1 and the C5 phenyl rings of 1,5-diarylpyrroles led to identification of 4-((1-(4-fluorophenyl)-2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-3-yl)methyl)thiomorpholine that is characterized by a very high activity toward both Mycobacterium tuberculosis 103471 and H37Rv strains (MIC values of 0.125μg/mL), and a safe profile in terms of cytotoxicity (CC(50) of >128μg/mL) and protection index (>1000). Antitubercular activity and protection index of the new compound are comparable to those found for the current antitubercular drugs streptomycin and rifampin.

[1]  Caminero Ja,et al.  Treatment of multidrug-resistant tuberculosis: evidence and controversies. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[3]  R. Chaisson,et al.  From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis , 2007, Nature Medicine.

[4]  Fabrizio Manetti,et al.  1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings. , 2008, Journal of medicinal chemistry.

[5]  R. Pompei,et al.  Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class. , 2005, Bioorganic & medicinal chemistry.

[6]  Avery,et al.  A new route to diastereomerically pure cyclopropanes utilizing stabilized phosphorus ylides and gamma-hydroxy enones derived from 1, 2-dioxines: mechanistic investigations and scope of reaction , 2000, The Journal of organic chemistry.

[7]  Rossella Fioravanti,et al.  Bactericidal Activities of the Pyrrole Derivative BM212 against Multidrug-Resistant and Intramacrophagic Mycobacterium tuberculosis Strains , 1998, Antimicrobial Agents and Chemotherapy.

[8]  R. Pompei,et al.  Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212. , 2003, Bioorganic & medicinal chemistry.

[9]  Fabrizio Manetti,et al.  1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation. , 2009, European journal of medicinal chemistry.

[10]  M. Espinal,et al.  The global situation of MDR-TB. , 2003, Tuberculosis.

[11]  Fabrizio Manetti,et al.  Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity. , 2006, Journal of medicinal chemistry.

[12]  M. Wilson,et al.  Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus. , 1990, Journal of medicinal chemistry.

[13]  M. Lipman,et al.  Tuberculosis and HIV Co-Infection , 2012, Drugs.

[14]  Q. Guo,et al.  Zinc-mediated chain extension reaction of 1,3-diketones to 1,4-diketones and diastereoselective synthesis of trans-1,2-disubstituted cyclopropanols. , 2006, The Journal of organic chemistry.